CIN- L67120MH1995PLC084899


Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID



Bacil Pharma Ltd.

NSE : BSE : 524516 ISIN CODE : INE711D01018Industry : Pharmaceuticals

News

  • Bacil Pharma - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 12Th August 2026 06 Aug 2026 | 19:33 | Dion Global

    Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and appr...more...

  • Bacil Pharma - Announcement Under Regulation 30, LODR 28 Jul 2026 | 18:32 | Dion Global

    Regarding the incorporation of a wholly owned subsidiary of the company named Bacil Research & Development Private Limited.more...
  • Bacil Pharma has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026 19 Jul 2026 | 18:10 | Dion Global

    As of June 2026 100.00% owned by Public.more...

  • Bacil Pharma - Attached Resignation Of Directors As Query Raised From BSE 18 Jul 2026 | 13:21 | Dion Global

    Attached Resignation of Directors as Query raised from BSEmore...
  • Bacil Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 14 Jul 2026 | 13:42 | Dion Global

    Compliance Certificate 74 (5) for the Quarter Ended 30th June 2026more...

  • Bacil Pharma - Announcement under Regulation 30 (LODR)-Change in Management 10 Jul 2026 | 15:24 | Dion Global

    Attached Resignation of Directors as query raised from BSEmore...
  • Bacil Pharma - Announcement under Regulation 30 (LODR)-Change in Management 09 Jul 2026 | 20:08 | Dion Global

    As Per Announcementmore...

  • Bacil Pharma - Announcement under Regulation 30 (LODR)-Raising of Funds 09 Jul 2026 | 20:07 | Dion Global

    As Per Announcementmore...
  • Bacil Pharma - Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of The SEBI (Listing Obligations 09 Jul 2026 | 20:05 | Dion Global

    As Per Announcementmore...

  • Bacil Pharma - Intimation Regarding Approval Of Name For Proposed Wholly-Owned Subsidiary 07 Jul 2026 | 19:16 | Dion Global

    Intimation regarding Approval of Name for Proposed Wholly-owned Subsidiarymore...
  • Bacil Pharma - Board Meeting Intimation for We Hereby Inform You That A Meeting Of The Board Of Directors Of The Company Is S 03 Jul 2026 | 18:54 | Dion Global

    Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/07/2026 inter alia to consider and appr...more...

  • Bacil Pharma - Intimation For Appointment Of Independent Director 30 Jun 2026 | 22:38 | Dion Global

    Intimation for Appointment of Independent Directormore...
  • Bacil Pharma - Withdrawal Of Intimation For Appointment Of Independent Directors 29 Jun 2026 | 23:38 | Dion Global

    Withdrawal of Intimation for Appointment of Independent Directorsmore...

  • Bacil Pharma - Announcement under Regulation 30 (LODR)-Change in Directorate 29 Jun 2026 | 18:22 | Dion Global

    Intimation of Appointment of Additional Non-Executive Independent Directormore...
  • Bacil Pharma - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On 26Th June, 2026 Pursuant To 26 Jun 2026 | 18:13 | Dion Global

    As per Attached outcome of meetingmore...

  • Bacil Pharma - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (Listing Obliga 23 Jun 2026 | 17:35 | Dion Global

    Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/06/2026 inter alia to consider...more...
  • Bacil Pharma - Intimation Of Proposed Incorporation Of Wholly-Owned Subsidiary 18 Jun 2026 | 14:49 | Dion Global

    Intimation of Proposed Incorporation of Wholly-Owned Subsidiarymore...

  • Bacil Pharma - Company Has Not Entered Any Related Party Transactions During The Half Year Ended 31St March, 2026. 22 May 2026 | 21:02 | Dion Global

    Company has not entered any Related Party Transactions during the half year ended 31st March 2026more...
  • Bacil Pharma - Statement Of Deviation Or Variation In Utilization Of Funds Under Regulation 32 Of The SEBI (Listing Obligatio 22 May 2026 | 20:59 | Dion Global

    Statement of Deviation or Variation in ultilization of Funds under Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regula...more...

  • Bacil Pharma - Audited Financial Results For 31St March, 2026 22 May 2026 | 20:49 | Dion Global

    Audited Financial Results for 31st March 2026more...
DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
More
Sensex78499.17-0.58%
NSE Index24570.65-0.26%
B500DIVL503610.360.20%
BSE 1000 11106.65-0.19%
BSE 100LCTMC9269.55-0.36%
BSE Auto 65073.811.33%
More

Commodity

Gold1491970.82%
Silver2321872.89%
Copper1396.3242.40%
Crude Oil735814.74%
Lead209.455.80%
Mentha Oil1331.324.72%
Nickel1651.8115.39%
More

Currency

USD/INR 95.21(0.00 %)
GBP/INR 128.12(-0.03 %)
EUR/INR 109.72(-0.20 %)
JPY/INR 0.60(-0.57 %)
CAD/INR 67.90(0.00 %)
HKD/INR 12.13(0.01 %)
More


Announcement Calendar

Previous monthAugust 2026Next month
MonTueWedThuFriSatSun
27282930311
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
123456
Upcoming

BOARD MEETINGS
Company Name : 3M India
Date : 14-08-2026

More

Latest Videos

Watch More Videos